Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves
- 17 May 2001
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 56 (4) , 478-486
- https://doi.org/10.1002/1097-4636(20010915)56:4<478::aid-jbm1119>3.0.co;2-c
Abstract
Bioprosthetic heart valves (BPHVs) derived from glutaraldehyde-crosslinked porcine aortic valves are frequently used in heart valve replacement surgeries. However, the majority of bioprostheses fail clinically because of calcification and degeneration. We have recently shown that glycosaminoglycan (GAG) loss may be in part responsible for degeneration of glutaraldehyde-crosslinked bioprostheses. In the present studies, we used a mild reaction of periodate-mediated crosslinking to stabilize glycosaminoglycans in the bioprosthetic tissue. We demonstrate the feasibility of periodate reaction by crosslinking major components of extracellular matrix of bioprosthetic heart valve tissue, namely type I collagen and hyaluronic acid (HA). Uronic acid assay of periodate-fixed HA-collagen matrices showed 48% of HA disaccharides were bound to collagen. Furthermore, we show that such reactions are also feasible to fix glycosaminoglycans present in the middle spongiosa layer of bioprosthetic heart valves. The periodate reactions were compatible with conventional glutaraldehyde crosslinking and showed adequate stabilization of extracellular matrix as demonstrated by thermal denaturation temperature and collagenase assays. Moreover, uronic acid assays of periodate-fixed BPHV cusps showed 36% reduction in the amount of unbound GAG disaccharides as compared with glutaraldehyde-crosslinked cusps. We also demonstrate that calcification of BPHV cusps was significantly reduced in the periodate-fixed group as compared with the glutaraldehyde-fixed group in 21-day rat subdermal calcification studies (periodate-fixed tissue Ca 72.01 ± 5.97 μg/mg, glutaraldehyde-fixed tissue Ca 107.25 ± 6.56 μg/mg). We conclude that periodate-mediated GAG fixation could reduce structural degeneration of BPHVs and may therefore increase the useful lifetime of these devices. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 56: 478–486, 2001Keywords
This publication has 30 references indexed in Scilit:
- In vivo behavior of epoxy-crosslinked porcine heart valve cusps and wallsJournal of Biomedical Materials Research, 2000
- Mechanisms of bioprosthetic heart valve failure: Fatigue causes collagen denaturation and glycosaminoglycan lossJournal of Biomedical Materials Research, 1999
- Role of Glutaraldehyde in Calcification of Porcine Aortic Valve FibroblastsThe American Journal of Pathology, 1999
- Does glutaraldehyde induce calcification of bioprosthetic tissues?The Annals of Thoracic Surgery, 1998
- A Mechanism for the Decrease in Stiffness of Bioprosthetic Heart Valve Tissues After Cross-LinkingAsaio Journal, 1996
- Role of Proteoglycan in the Provisional Calcification of CartilageClinical Orthopaedics and Related Research, 1991
- Analysis of the bending behaviour of porcine xenograft leaflets and of natural aortic valve material: Bending stiffness, neutral axis and shear measurementsJournal of Biomechanics, 1989
- Bone mineral and glycosaminoglycans in newborn and mature rabbitsJournal of Bone and Mineral Research, 1988
- Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stressThe American Journal of Cardiology, 1986
- Acid mucopolysaccharide composition of human-heart valveBiochimica et Biophysica Acta (BBA) - Mucoproteins and Mucopolysaccharides, 1965